French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund sparked a new political backlash, stoked by fears the deal marks a loss of sovereignty over key medications.
From
To
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.
The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry from politicians on all sides.
According to the Cleveland Clinic, more than 50 million people in the United States have a sleep disorder. As more people seek out alternative…